Sep 22, 2026 8 0
Uploaded by Eden
Favorite
Share
More Options
11
First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors_Page 1

Open in WPS to view all 11 pages